Marietta Investment Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $855K | Buy |
12,230
+936
| +8% | +$65.4K | 0.19% | 98 |
|
|
2025
Q1 | $830K | Sell |
11,294
-14
| -0.1% | -$1.03K | 0.2% | 90 |
|
|
2024
Q4 | $741K | Sell |
11,308
-2,622
| -19% | -$172K | 0.16% | 101 |
|
|
2024
Q3 | $1.09M | Sell |
13,930
-10
| -0.1% | -$779 | 0.23% | 81 |
|
|
2024
Q2 | $1.09M | Sell |
13,940
-10
| -0.1% | -$780 | 0.24% | 78 |
|
|
2024
Q1 | $945K | Sell |
13,950
-2,731
| -16% | -$185K | 0.21% | 88 |
|
|
2023
Q4 | $1.12M | Sell |
16,681
-61,438
| -79% | -$4.14M | 0.28% | 78 |
|
|
2023
Q3 | $5.29M | Sell |
78,119
-4
| -0% | -$271 | 1.48% | 21 |
|
|
2023
Q2 | $5.59M | Buy |
78,123
+62,089
| +387% | +$4.44M | 1.45% | 23 |
|
|
2023
Q1 | $1.11M | Sell |
16,034
-286
| -2% | -$19.9K | 0.31% | 66 |
|
|
2022
Q4 | $1.11M | Buy |
16,320
+258
| +2% | +$17.5K | 0.31% | 68 |
|
|
2022
Q3 | $980K | Buy |
16,062
+99
| +0.6% | +$6.04K | 0.29% | 68 |
|
|
2022
Q2 | $1.06M | Buy |
15,963
+1,387
| +10% | +$91.7K | 0.31% | 70 |
|
|
2022
Q1 | $967K | Buy |
14,576
+3,176
| +28% | +$211K | 0.22% | 87 |
|
|
2021
Q4 | $664K | Hold |
11,400
| – | – | 0.14% | 112 |
|
|
2021
Q3 | $685K | Hold |
11,400
| – | – | 0.16% | 107 |
|
|
2021
Q2 | $683K | Sell |
11,400
-215
| -2% | -$12.9K | 0.16% | 104 |
|
|
2021
Q1 | $577K | Buy |
11,615
+500
| +4% | +$24.8K | 0.14% | 108 |
|
|
2020
Q4 | $556K | Sell |
11,115
-16,138
| -59% | -$807K | 0.14% | 101 |
|
|
2020
Q3 | $1.49M | Buy |
27,253
+790
| +3% | +$43.3K | 0.45% | 47 |
|
|
2020
Q2 | $1.4M | Buy |
26,463
+17,166
| +185% | +$908K | 0.47% | 49 |
|
|
2020
Q1 | $415K | Buy |
9,297
+2,863
| +44% | +$128K | 0.18% | 83 |
|
|
2019
Q4 | $321K | Buy |
+6,434
| New | +$321K | 0.1% | 126 |
|